<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>CatsWannaBeCats.Com | Walters Fulton | Activity</title>
	<link>https://www.catswannabecats.com/members/antbit68/activity/</link>
	<atom:link href="https://www.catswannabecats.com/members/antbit68/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Walters Fulton.</description>
	<lastBuildDate>Sat, 04 Jul 2026 08:03:39 -0400</lastBuildDate>
	<generator>https://buddypress.org/?v=7.2.0</generator>
	<language>en-CA</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">6e38d7c163704927e6bb1e424c8e1788</guid>
				<title>Walters Fulton posted an update: 6 years) and 52% of participants were males. At 30 days, [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/14867/</link>
				<pubDate>Mon, 02 Jun 2025 09:48:40 -0400</pubDate>

									<content:encoded><![CDATA[<p>6 years) and 52% of participants were males. At 30 days, 293/324 (90.43%) completed the program, and 203 of these (63%) were successfully connected to a subsequent community addiction medicine physician. There was a significant improvement (36%) in health-related quality of life.</p>
<p> Lack of insurance is a predictor for treatment failure.&hellip;<span class="activity-read-more" id="activity-read-more-14867"><a href="https://www.catswannabecats.com/activity/p/14867/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">4aeee4b2d64cc6d05e293dec04483087</guid>
				<title>Walters Fulton posted an update: Cutaneous T-cell lymphomas (CTCL) are rare non-Hodgkin [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/5002/</link>
				<pubDate>Sat, 31 May 2025 14:22:31 -0400</pubDate>

									<content:encoded><![CDATA[<p>Cutaneous T-cell lymphomas (CTCL) are rare non-Hodgkin lymphomas with a generally indolent course managed with topical, skin-directed therapies. A small subset, however, will progress to advanced stage disease necessitating systemic therapy for disease control. Currently approved therapies have low response rates and generally short durations of&hellip;<span class="activity-read-more" id="activity-read-more-5002"><a href="https://www.catswannabecats.com/activity/p/5002/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">4ae6b1467aa6d13e9a118aa873681fd4</guid>
				<title>Walters Fulton became a registered member</title>
				<link>https://www.catswannabecats.com/activity/p/4806/</link>
				<pubDate>Sat, 31 May 2025 14:08:31 -0400</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>